149 related articles for article (PubMed ID: 11556749)
1. Immunoexpression of inhibin alpha-subunit in adrenal neoplasms.
Cho EY; Ahn GH
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):222-8. PubMed ID: 11556749
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
Elmoneim HM; Samaka RM; Ali H
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.
McCluggage WG; Burton J; Maxwell P; Sloan JM
J Clin Pathol; 1998 Feb; 51(2):114-6. PubMed ID: 9602683
[TBL] [Abstract][Full Text] [Related]
5. The alpha subunit of inhibin in adrenal cortical neoplasia.
Pelkey TJ; Frierson HF; Mills SE; Stoler MH
Mod Pathol; 1998 Jun; 11(6):516-24. PubMed ID: 9647588
[TBL] [Abstract][Full Text] [Related]
6. Expression of inhibin alpha in the human adrenal gland and adrenocortical tumors.
Arola J; Liu J; Heikkilä P; Voutilainen R; Kahri A
Endocr Res; 1998; 24(3-4):865-7. PubMed ID: 9888589
[TBL] [Abstract][Full Text] [Related]
7. Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.
Salmenkivi K; Arola J; Voutilainen R; Ilvesmäki V; Haglund C; Kahri AI; Heikkilä P; Liu J
J Clin Endocrinol Metab; 2001 May; 86(5):2231-5. PubMed ID: 11344232
[TBL] [Abstract][Full Text] [Related]
8. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
9. BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study.
Fogt F; Zimmerman RL; Mulligan N; Vortmeyer AO; Poremba C; Harris CA; Alsaigh N; Tomaszewski JE; Nikulasson ST
Int J Mol Med; 1999 Mar; 3(3):271-4. PubMed ID: 10028050
[TBL] [Abstract][Full Text] [Related]
10. Inhibin alpha-subunit, Melan A and MNF116 in pheochromocytomas.
Păun D; Neamţu MC; Avramescu ET; Georgescu MG; Petriş R; Terzea D; Poiană C; Păun S
Rom J Morphol Embryol; 2014; 55(3):905-8. PubMed ID: 25329118
[TBL] [Abstract][Full Text] [Related]
11. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
Renshaw AA; Granter SR
Mod Pathol; 1998 Dec; 11(12):1160-4. PubMed ID: 9872645
[TBL] [Abstract][Full Text] [Related]
12. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
13. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.
Arola J; Liu J; Heikkilä P; Ilvesmäki V; Salmenkivi K; Voutilainen R; Kahri AI
J Endocrinol; 2000 May; 165(2):223-9. PubMed ID: 10810286
[TBL] [Abstract][Full Text] [Related]
14. [The expression of A103 and inhibin alpha in adrenocortical adenoma by high-throughput tissue microarray techniques].
Zhang H; Liu W; Wang X; Li G; Guo J; Li F; Liao D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):424-6. PubMed ID: 12910679
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic utility of inhibin staining in ovarian neoplasms.
Pelkey TJ; Frierson HF; Mills SE; Stoler MH
Int J Gynecol Pathol; 1998 Apr; 17(2):97-105. PubMed ID: 9553804
[TBL] [Abstract][Full Text] [Related]
16. Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers.
Zheng W; Sung CJ; Hanna I; DePetris G; Lambert-Messerlian G; Steinhoff M; Lauchlan SC
Int J Gynecol Pathol; 1997 Jul; 16(3):263-71. PubMed ID: 9421093
[TBL] [Abstract][Full Text] [Related]
17. Melan-A (A103) and inhibin expression in ovarian neoplasms.
Yao DX; Soslow RA; Hedvat CV; Leitao M; Baergen RN
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):244-9. PubMed ID: 12966351
[TBL] [Abstract][Full Text] [Related]
18. The expression of inhibin/activin subunits in the human adrenal cortex and its tumours.
Munro LM; Kennedy A; McNicol AM
J Endocrinol; 1999 May; 161(2):341-7. PubMed ID: 10320833
[TBL] [Abstract][Full Text] [Related]
19. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
Marino FE; Risbridger G; Gold E
Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
